NMC.L Regulatory News (NMC)

24th December 2012

NMC HEALTH PLCNotification of transactions of a director, person discharging managerial responsibility or connected personsNMC Health plc (the "Company") announces that it was notified on 21 December 2012 that connected persons to Lord Clanwilliam, a non-executive director of the Company, purchased ordinary shares of 10p each in the Company ("Shares"). The Shares were purchased at an average price of 172.28 pence per Share and the details of the purchases are set out below.

Both the above are deemed to be connected persons of Lord Clanwilliam by virtue of being under the age of 18 years.

The Company has also been notified that Lady Tamara Meade, Lord Clanwilliam's daughter above the age of 18 years, has also purchased 2,865 Shares at an average price of 172.28 pence per share, however these are not declared as an interest of Lord Clanwilliam given Lady Meade's age.

Following this purchase, Lord Clanwilliam has an interest in a total of 8,597 Shares, representing approximately 0.01% of the issued share capital of the Company.

- ENDS -

About NMC Healthcare

NMC Health plc is a leading integrated healthcare provider with operations in the United Arab Emirates. NMC Healthcare commenced operations in 1975 and has grown over that period to become the only private sector healthcare provider with a broad UAE presence. The Healthcare Division currently operates four hospitals, two day-care medical centre and eight pharmacies. The group also operates a significant distribution business supplying over 65,000 product lines to UAE customers across the Pharmaceutical, FMCG, Food, Scientific and Medical, Educational and Veterinary sectors.

In April 2012 NMC Health plc was listed on the Premium Segment of the London Stock Exchange and is a constituent of the FTSE 250 index. At the time of its IPO, the group raised funds to enable it to pursue a further growth plan with a number of capital projects for new healthcare facilities in Abu Dhabi and Dubai.

www.nmchealthcare.com 

For further information please contact: